Benzinga | Oct 11, 2021 11:44AM EDT

William Blair Downgrades Adamas Pharmaceuticals to Market Perform

William Blair analyst Tim Lugo downgrades Adamas Pharmaceuticals (NASDAQ:ADMS) from Outperform to Market Perform.